Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance
US-9839684-B2 · Dec 12, 2017 · US
US9243299B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9243299-B2 |
| Application number | US-201113582739-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 4, 2011 |
| Priority date | Mar 4, 2010 |
| Publication date | Jan 26, 2016 |
| Grant date | Jan 26, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to a newly identified avian rotavirus D VP6 nucleotide sequence and uses thereof.
Opening claim text (preview).
The invention claimed is: 1. A nucleic acid comprising: (a) a nucleic acid sequence with at least 90% identity to the nucleic acid sequence as recited in SEQ ID NO: 1; (b) a nucleic acid sequence with at least 90% identity to the reverse complement of the nucleic acid sequence as recited in SEQ ID NO: 1; (c) a fragment of the nucleic acid sequence as recited in SEQ ID NO: 1 that consists of at least 24 consecutive nucleotides from SEQ ID NO: 1; (d) a fragment of the reverse…
Chemistry & Metallurgy · mapped topic
Physics · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.